These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27162551)

  • 1. Synthesis and Preclinical Evaluation of a Highly Improved Anticancer Prodrug Activated by Histone Deacetylases and Cathepsin L.
    Ueki N; Wang W; Swenson C; McNaughton C; Sampson NS; Hayman MJ
    Theranostics; 2016; 6(6):808-16. PubMed ID: 27162551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease.
    Ueki N; Lee S; Sampson NS; Hayman MJ
    Nat Commun; 2013; 4():2735. PubMed ID: 24193185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
    Akinboye ES; Rosen MD; Bakare O; Denmeade SR
    Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP-1.
    Xu Z; Hu W; Wang Z; Gou S
    Eur J Med Chem; 2017 Dec; 141():211-220. PubMed ID: 29031068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.
    Wen J; Bao Y; Niu Q; Yang J; Fan Y; Li J; Jing Y; Zhao L; Liu D
    Eur J Med Chem; 2016 Feb; 109():350-9. PubMed ID: 26814680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of anticancer activity of BOC26P, an ortho-aryl chalcone sodium phosphate as water-soluble prodrugs in vitro and in vivo.
    Zhu C; Wang R; Zheng W; Chen D; Yue X; Cao Y; Qin W; Sun H; Wang Y; Liu Z; Li B; Du J; Bu X; Zhou B
    Biomed Pharmacother; 2017 Dec; 96():551-562. PubMed ID: 29032339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
    Janssen S; Jakobsen CM; Rosen DM; Ricklis RM; Reineke U; Christensen SB; Lilja H; Denmeade SR
    Mol Cancer Ther; 2004 Nov; 3(11):1439-50. PubMed ID: 15542783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: an experimental study.
    Shao LH; Liu SP; Hou JX; Zhang YH; Peng CW; Zhong YJ; Liu X; Liu XL; Hong YP; Firestone RA; Li Y
    Cancer; 2012 Jun; 118(11):2986-96. PubMed ID: 22006342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of a Conjugate of 5-Fluorouracil and an LSD1 Inhibitor.
    Ota Y; Nakamura A; Elboray EE; Itoh Y; Suzuki T
    Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):192-195. PubMed ID: 30369513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B.
    Warnecke A; Fichtner I; Sass G; Kratz F
    Arch Pharm (Weinheim); 2007 Aug; 340(8):389-95. PubMed ID: 17628030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard.
    Chakravarty PK; Carl PL; Weber MJ; Katzenellenbogen JA
    J Med Chem; 1983 May; 26(5):633-8. PubMed ID: 6221099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L.
    Parker EN; Odutola SO; Wang Y; Strecker TE; Mukherjee R; Shi Z; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1304-1310. PubMed ID: 28117205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug strategy for cancer cell-specific targeting: A recent overview.
    Zhang X; Li X; You Q; Zhang X
    Eur J Med Chem; 2017 Oct; 139():542-563. PubMed ID: 28837920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
    Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
    Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents.
    Dichiara M; Amata E; Rescifina A; Prezzavento O; Floresta G; Parenti C; Pittalà V; Marrazzo A
    Future Med Chem; 2017 Oct; 9(15):1749-1764. PubMed ID: 28869398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrug Mono Therapy: synthesis and biological evaluation of an etoposide glucuronide-prodrug.
    Schmidt F; Monneret C
    Bioorg Med Chem; 2003 May; 11(10):2277-83. PubMed ID: 12713838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models.
    Spangler B; Fontaine SD; Shi Y; Sambucetti L; Mattis AN; Hann B; Wells JA; Renslo AR
    J Med Chem; 2016 Dec; 59(24):11161-11170. PubMed ID: 27936709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Characterization and in vitro Studies of a Cathepsin B-Cleavable Prodrug of the VEGFR Inhibitor Sunitinib.
    Karnthaler-Benbakka C; Koblmüller B; Mathuber M; Holste K; Berger W; Heffeter P; Kowol CR; Keppler BK
    Chem Biodivers; 2019 Jan; 16(1):e1800520. PubMed ID: 30566287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.